BioNews Results for TLR9:  |  |
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C V
Therapeutics Daily: Nov 3 2009 5:20PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C V
Pharma Live: Nov 3 2009 5:09PM Matching: tlr9
|
Idera Pharma (IDRA) Presents IMO-2125 Preclinical Data
Street Insider: Nov 3 2009 2:53PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C V
Genetic Engineering News: Nov 3 2009 1:57PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C V
Business Wire: Nov 3 2009 1:23PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
Yahoo! Canada: Nov 3 2009 4:40PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
Individual.com: Nov 3 2009 5:50PM Matching: tlr9
|
AASLD Liver Meeting Starts Today in Boston
HIV and Hepatitis.com: Oct 30 2009 2:18AM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Recep
Pharma Live: Oct 23 2009 11:51AM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Recep
PharmiWeb: Oct 22 2009 4:14PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel in Arthritis Model
SmartBrief: Oct 19 2009 5:46PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Recep
Genetic Engineering News: Oct 19 2009 2:21PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Recep
PR inside: Oct 19 2009 1:28PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel in Arthritis Model
FinanzNachrichten.de: Oct 19 2009 1:18PM Matching: tlr9
|
Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel in Arthritis Model
FinanzNachrichten.de: Oct 19 2009 1:16PM Matching: tlr9
|
